Back to Search
Start Over
Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis.
- Source :
-
Respiratory investigation [Respir Investig] 2024 Jul; Vol. 62 (4), pp. 610-616. Date of Electronic Publication: 2024 May 04. - Publication Year :
- 2024
-
Abstract
- Background: Pulmonary alveolar proteinosis (PAP) is characterized by an abnormal accumulation of surfactants in the alveoli. Most cases are classified as autoimmune PAP (APAP) because they are associated with autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). However, GM-CSF autoantibody levels are unlikely to correlate with the disease severity or prognosis of APAP.<br />Methods: We collected clinical records and measured 38 serum cytokine concentrations for consecutive patients with APAP. After exclusion of 21 cytokines because of undetectable levels, 17 cytokine levels were compared between low and high disease severity scores (DSSs). We also compared whole lung lavage (WLL)-free survival with cut-off values defined by receiver operating characteristic (ROC) curves of cytokine levels and WLL administration at 11 months.<br />Results: Nineteen patients with APAP were enrolled in the study. Five were classified as DSS 1 or 2, while the others were classified as DSS 4 or 5. Comparison between DSS 1-2 and 4-5 revealed that the concentrations of IP-10 and GRO increased in the latter groups (p < 0.05). Fifteen patients underwent WLL. Comparison between those who underwent WLL within 11 months and the others showed that IP-10 and TNF-α were tended to be elevated in the former group (p = 0.082 and 0.057, respectively). The cut-off values of IP-10, 308.8 pg/mL and TNF-α, 19.1 pg/mL, defined by the ROC curves, significantly separated WLL-free survivals with log-rank analyses (p = 0.005).<br />Conclusions: The concentrations of IP-10 and GRO may reflect the DSSs of APAP. A combination of IP-10 and TNF-α levels could be a biomarker to predict WLL-free survival.<br />Competing Interests: Declaration of competing interest The authors have no conflicts of interest.<br /> (Copyright © 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Humans
Prognosis
Male
Female
Middle Aged
Adult
Autoantibodies blood
Chemokine CXCL10 blood
Aged
Tumor Necrosis Factor-alpha blood
Biomarkers blood
Bronchoalveolar Lavage
Young Adult
Pulmonary Alveolar Proteinosis immunology
Pulmonary Alveolar Proteinosis diagnosis
Pulmonary Alveolar Proteinosis blood
Pulmonary Alveolar Proteinosis therapy
Severity of Illness Index
Cytokines blood
Autoimmune Diseases immunology
Autoimmune Diseases blood
Autoimmune Diseases diagnosis
Granulocyte-Macrophage Colony-Stimulating Factor blood
Subjects
Details
- Language :
- English
- ISSN :
- 2212-5353
- Volume :
- 62
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Respiratory investigation
- Publication Type :
- Academic Journal
- Accession number :
- 38705133
- Full Text :
- https://doi.org/10.1016/j.resinv.2024.04.019